{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:20:37Z","timestamp":1792516837140,"version":"4.5.0"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82160599"],"award-info":[{"award-number":["No.82160599"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06627-8","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:04:52Z","timestamp":1751360692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The immunological pathogenesis of vitiligo and the potential role of mesenchymal stromal\/stem cells in its treatment"],"prefix":"10.1186","volume":"23","author":[{"given":"Rui-Lin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Zhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Bing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Xiao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zu-Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6930-8001","authenticated-orcid":false,"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"6627_CR1","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/bjd.16926","volume":"179","author":"N Joly-Tonetti","year":"2018","unstructured":"Joly-Tonetti N, Wibawa JID, Bell M, Tobin DJ. An explanation for the mysterious distribution of melanin in human skin: a rare example of asymmetric (melanin) organelle distribution during mitosis of basal layer progenitor keratinocytes. Br J Dermatol. 2018;179:1115\u201326. https:\/\/doi.org\/10.1111\/bjd.16926.","journal-title":"Br J Dermatol"},{"key":"6627_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5114\/pdia.2013.33376","volume":"30","author":"M Cichorek","year":"2013","unstructured":"Cichorek M, Wachulska M, Stasiewicz A, Tymi\u0144ska A. Skin melanocytes: biology and development. Postepy Dermatol Alergol. 2013;30:30\u201341. https:\/\/doi.org\/10.5114\/pdia.2013.33376.","journal-title":"Postepy Dermatol Alergol"},{"key":"6627_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1751-1097.2007.00226.x","volume":"84","author":"M Brenner","year":"2008","unstructured":"Brenner M, Hearing VJ. The protective role of melanin against UV damage in human skin. Photochem Photobiol. 2008;84:539\u201349. https:\/\/doi.org\/10.1111\/j.1751-1097.2007.00226.x.","journal-title":"Photochem Photobiol"},{"key":"6627_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.5021\/ad.2016.28.3.279","volume":"28","author":"E Bastonini","year":"2016","unstructured":"Bastonini E, Kovacs D, Picardo M. Skin pigmentation and pigmentary disorders: focus on epidermal\/dermal cross-talk. Ann Dermatol. 2016;28:279\u201389. https:\/\/doi.org\/10.5021\/ad.2016.28.3.279.","journal-title":"Ann Dermatol"},{"key":"6627_CR5","doi-asserted-by":"publisher","unstructured":"Hida T, Kamiya T, Kawakami A, Ogino J, Sohma H, Uhara H, et al. Elucidation of melanogenesis cascade for identifying pathophysiology and therapeutic approach of pigmentary disorders and melanoma. Int J Mol Sci. 2020;21. https:\/\/doi.org\/10.3390\/ijms21176129.","DOI":"10.3390\/ijms21176129"},{"key":"6627_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/pcmr.12067","volume":"26","author":"B Watt","year":"2013","unstructured":"Watt B, van Niel G, Raposo G, Marks MS. PMEL: a pigment cell-specific model for functional amyloid formation. Pigment Cell Melanoma Res. 2013;26:300\u201315. https:\/\/doi.org\/10.1111\/pcmr.12067.","journal-title":"Pigment Cell Melanoma Res"},{"key":"6627_CR7","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm2258","volume":"8","author":"G Raposo","year":"2007","unstructured":"Raposo G, Marks MS. Melanosomes\u2013dark organelles enlighten endosomal membrane transport. Nat Rev Mol Cell Biol. 2007;8:786\u201397. https:\/\/doi.org\/10.1038\/nrm2258.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6627_CR8","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1091\/mbc.12.11.3451","volume":"12","author":"JF Berson","year":"2001","unstructured":"Berson JF, Harper DC, Tenza D, Raposo G, Marks MS. Pmel17 initiates premelanosome morphogenesis within multivesicular bodies. Mol Biol Cell. 2001;12:3451\u201364. https:\/\/doi.org\/10.1091\/mbc.12.11.3451.","journal-title":"Mol Biol Cell"},{"key":"6627_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/s1357-2725(01)00068-1","volume":"33","author":"M Mart\u00ednez-Esparza","year":"2001","unstructured":"Mart\u00ednez-Esparza M, Ferrer C, Castells MT, Garc\u00eda-Borr\u00f3n JC, Zuasti A. Transforming growth factor beta1 mediates hypopigmentation of B16 mouse melanoma cells by inhibition of melanin formation and melanosome maturation. Int J Biochem Cell Biol. 2001;33:971\u201383. https:\/\/doi.org\/10.1016\/s1357-2725(01)00068-1.","journal-title":"Int J Biochem Cell Biol"},{"key":"6627_CR10","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1016\/j.cell.2021.06.022","volume":"184","author":"J Allouche","year":"2021","unstructured":"Allouche J, Rachmin I, Adhikari K, Pardo LM, Lee JH, McConnell AM, et al. NNT mediates redox-dependent pigmentation via a UVB- and MITF-independent mechanism. Cell. 2021;184:4268\u2013e42834220. https:\/\/doi.org\/10.1016\/j.cell.2021.06.022.","journal-title":"Cell"},{"key":"6627_CR11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/php.12335","volume":"91","author":"TH Nasti","year":"2015","unstructured":"Nasti TH, Timares L. MC1R, eumelanin and pheomelanin: their role in determining the susceptibility to skin cancer. Photochem Photobiol. 2015;91:188\u2013200. https:\/\/doi.org\/10.1111\/php.12335.","journal-title":"Photochem Photobiol"},{"key":"6627_CR12","doi-asserted-by":"publisher","unstructured":"Kovacs D, Cardinali G, Picardo M, Bastonini E. Shining light on autophagy in skin pigmentation and pigmentary disorders. Cells. 2022;11. https:\/\/doi.org\/10.3390\/cells11192999.","DOI":"10.3390\/cells11192999"},{"key":"6627_CR13","doi-asserted-by":"publisher","unstructured":"Lee SE, Kim MJ, Hillman PF, Oh DC, Fenical W, Nam SJ, et al. Deoxyvasicinone with anti-melanogenic activity from marine-derived streptomyces sp. CNQ-617. Mar Drugs. 2022;20. https:\/\/doi.org\/10.3390\/md20020155.","DOI":"10.3390\/md20020155"},{"key":"6627_CR14","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nature05660","volume":"445","author":"JY Lin","year":"2007","unstructured":"Lin JY, Fisher DE. Melanocyte biology and skin pigmentation. Nature. 2007;445:843\u201350. https:\/\/doi.org\/10.1038\/nature05660.","journal-title":"Nature"},{"key":"6627_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/00008390-199610000-00001","volume":"6","author":"AJ Nappi","year":"1996","unstructured":"Nappi AJ, Vass E. Hydrogen peroxide generation associated with the oxidations of the eumelanin precursors 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid. Melanoma Res. 1996;6:341\u20139. https:\/\/doi.org\/10.1097\/00008390-199610000-00001.","journal-title":"Melanoma Res"},{"key":"6627_CR16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.5604\/17322693.1208033","volume":"70","author":"Z Rzepka","year":"2016","unstructured":"Rzepka Z, Buszman E, Beberok A, Wrze\u015bniok D. From tyrosine to melanin: signaling pathways and factors regulating melanogenesis. Postepy Hig Med Dosw (Online). 2016;70:695\u2013708. https:\/\/doi.org\/10.5604\/17322693.1208033.","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"6627_CR17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/bjd.18902","volume":"183","author":"C Martins","year":"2020","unstructured":"Martins C, Darrigade AS, Jacquemin C, Barnetche T, Taieb A, Ezzedine K, et al. Phenotype and function of circulating memory T cells in human vitiligo. Br J Dermatol. 2020;183:899\u2013908. https:\/\/doi.org\/10.1111\/bjd.18902.","journal-title":"Br J Dermatol"},{"key":"6627_CR18","doi-asserted-by":"publisher","unstructured":"Boniface K, Seneschal J, Picardo M, Taieb A. Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy. Clin Rev Allergy Immunol. 2018;54:52\u201367. https:\/\/doi.org\/10.1007\/s12016-017-8622-7.","DOI":"10.1007\/s12016-017-8622-7"},{"key":"6627_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1159\/000506103","volume":"236","author":"C Bergqvist","year":"2020","unstructured":"Bergqvist C, Ezzedine K. Vitiligo: a review. Dermatology. 2020;236:571\u201392. https:\/\/doi.org\/10.1159\/000506103.","journal-title":"Dermatology"},{"key":"6627_CR20","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","volume":"25","author":"K Ezzedine","year":"2012","unstructured":"Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, et al. Revised classification\/nomenclature of vitiligo and related issues: the vitiligo global issues consensus conference. Pigment Cell Melanoma Res. 2012;25:E1\u201313. https:\/\/doi.org\/10.1111\/j.1755-148X.2012.00997.x.","journal-title":"Pigment Cell Melanoma Res"},{"key":"6627_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1365-4362.1982.tb02070.x","volume":"21","author":"RA Miller","year":"1982","unstructured":"Miller RA. The Koebner phenomenon. Int J Dermatol. 1982;21:192\u20137. https:\/\/doi.org\/10.1111\/j.1365-4362.1982.tb02070.x.","journal-title":"Int J Dermatol"},{"key":"6627_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1056\/NEJMcp0804388","volume":"360","author":"A Ta\u00efeb","year":"2009","unstructured":"Ta\u00efeb A, Picardo M. Clinical practice. Vitiligo. N Engl J Med. 2009;360:160\u20139. https:\/\/doi.org\/10.1056\/NEJMcp0804388.","journal-title":"N Engl J Med"},{"key":"6627_CR23","unstructured":"Sanchez DP, Sonthalia S. Koebner phenomenon. StatPearls. StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC. Treasure Island (FL). 2024."},{"key":"6627_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12016-021-08868-z","volume":"61","author":"Y Wang","year":"2021","unstructured":"Wang Y, Li S, Li C. Clinical features, immunopathogenesis, and therapeutic strategies in vitiligo. Clin Rev Allergy Immunol. 2021;61:299\u2013323. https:\/\/doi.org\/10.1007\/s12016-021-08868-z.","journal-title":"Clin Rev Allergy Immunol"},{"key":"6627_CR25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s40257-013-0039-3","volume":"14","author":"CR Camara-Lemarroy","year":"2013","unstructured":"Camara-Lemarroy CR, Salas-Alanis JC. The role of tumor necrosis factor-\u03b1 in the pathogenesis of vitiligo. Am J Clin Dermatol. 2013;14:343\u201350. https:\/\/doi.org\/10.1007\/s40257-013-0039-3.","journal-title":"Am J Clin Dermatol"},{"key":"6627_CR26","doi-asserted-by":"publisher","unstructured":"Le Poole IC, Wa\u00f1kowicz-Kali\u00f1ska A, van den Wijngaard RM, Nickoloff BJ, Das PK. Autoimmune aspects of depigmentation in vitiligo. J Investig Dermatol Symp Proc. 2004;9:68\u201372. https:\/\/doi.org\/10.1111\/j.1087-0024.2004.00825.x.","DOI":"10.1111\/j.1087-0024.2004.00825.x"},{"key":"6627_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.det.2016.11.014","volume":"35","author":"M Rashighi","year":"2017","unstructured":"Rashighi M, Harris JE. Vitiligo pathogenesis and emerging treatments. Dermatol Clin. 2017;35:257\u201365. https:\/\/doi.org\/10.1016\/j.det.2016.11.014.","journal-title":"Dermatol Clin"},{"key":"6627_CR28","doi-asserted-by":"publisher","first-page":"790125","DOI":"10.3389\/fimmu.2021.790125","volume":"12","author":"F Qi","year":"2021","unstructured":"Qi F, Liu F, Gao L. Janus kinase inhibitors in the treatment of vitiligo: a review. Front Immunol. 2021;12:790125. https:\/\/doi.org\/10.3389\/fimmu.2021.790125.","journal-title":"Front Immunol"},{"key":"6627_CR29","doi-asserted-by":"publisher","unstructured":"Okoro U, Usatine RP, Heath CR, Vitiligo. Cutis. 2023;111:106\u20137. https:\/\/doi.org\/10.12788\/cutis.0693.","DOI":"10.12788\/cutis.0693"},{"key":"6627_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.imbio.2019.04.004","volume":"224","author":"ZP Guinn","year":"2019","unstructured":"Guinn ZP, Petro TM. Interferon regulatory factor 3 plays a role in macrophage responses to interferon-\u03b3. Immunobiology. 2019;224:565\u201374. https:\/\/doi.org\/10.1016\/j.imbio.2019.04.004.","journal-title":"Immunobiology"},{"key":"6627_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol. 2005;5:375\u201386. https:\/\/doi.org\/10.1038\/nri1604.","journal-title":"Nat Rev Immunol"},{"key":"6627_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4132\/jptm.2018.09.18","volume":"52","author":"AG Abdou","year":"2018","unstructured":"Abdou AG, Maraee A, Yassien H, Sarhan M. Immunohistochemistry of Janus kinase 1 (JAK1) expression in vitiligo. J Pathol Transl Med. 2018;52:363\u20138. https:\/\/doi.org\/10.4132\/jptm.2018.09.18.","journal-title":"J Pathol Transl Med"},{"key":"6627_CR33","doi-asserted-by":"publisher","first-page":"223ra223","DOI":"10.1126\/scitranslmed.3007811","volume":"6","author":"M Rashighi","year":"2014","unstructured":"Rashighi M, Agarwal P, Richmond JM, Harris TH, Dresser K, Su MW, et al. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Sci Transl Med. 2014;6:223ra223. https:\/\/doi.org\/10.1126\/scitranslmed.3007811.","journal-title":"Sci Transl Med"},{"key":"6627_CR34","doi-asserted-by":"publisher","unstructured":"Reynders N, Abboud D, Baragli A, Noman MZ, Rogister B, Niclou SP, et al. The distinct roles of CXCR3 variants and their ligands in the tumor microenvironment. Cells. 2019;8. https:\/\/doi.org\/10.3390\/cells8060613.","DOI":"10.3390\/cells8060613"},{"key":"6627_CR35","doi-asserted-by":"publisher","first-page":"1022688","DOI":"10.3389\/fonc.2022.1022688","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Zhang Y, Wang S, Ni H, Zhao P, Chen G, et al. The role of CXCR3 and its ligands in cancer. Front Oncol. 2022;12:1022688. https:\/\/doi.org\/10.3389\/fonc.2022.1022688.","journal-title":"Front Oncol"},{"key":"6627_CR36","doi-asserted-by":"publisher","first-page":"154809","DOI":"10.1016\/j.cyto.2019.154809","volume":"125","author":"M Puchert","year":"2020","unstructured":"Puchert M, Obst J, Koch C, Zieger K, Engele J. CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7. Cytokine. 2020;125:154809. https:\/\/doi.org\/10.1016\/j.cyto.2019.154809.","journal-title":"Cytokine"},{"key":"6627_CR37","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","volume":"10","author":"MK Tulic","year":"2019","unstructured":"Tulic MK, Cavazza E, Cheli Y, Jacquel A, Luci C, Cardot-Leccia N, et al. Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo. Nat Commun. 2019;10:2178. https:\/\/doi.org\/10.1038\/s41467-019-09963-8.","journal-title":"Nat Commun"},{"key":"6627_CR38","doi-asserted-by":"publisher","unstructured":"Hla\u010da N, \u017dagar T, Ka\u0161telan M, Brajac I, Prpi\u0107-Massari L. Current concepts of vitiligo immunopathogenesis. Biomedicines. 2022;10. https:\/\/doi.org\/10.3390\/biomedicines10071639.","DOI":"10.3390\/biomedicines10071639"},{"key":"6627_CR39","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2340\/00015555-2080","volume":"95","author":"L Yang","year":"2015","unstructured":"Yang L, Wei Y, Sun Y, Shi W, Yang J, Zhu L, et al. Interferon-gamma inhibits melanogenesis and induces apoptosis in melanocytes: a pivotal role of CD8\u2009+\u2009cytotoxic T lymphocytes in vitiligo. Acta Derm Venereol. 2015;95:664\u201370. https:\/\/doi.org\/10.2340\/00015555-2080.","journal-title":"Acta Derm Venereol"},{"key":"6627_CR40","doi-asserted-by":"publisher","first-page":"e2250281","DOI":"10.1002\/eji.202250281","volume":"54","author":"H Liu","year":"2024","unstructured":"Liu H, Wang Y, Le Q, Tong J, Wang H. The IFN-\u03b3-CXCL9\/CXCL10-CXCR3 axis in vitiligo: pathological mechanism and treatment. Eur J Immunol. 2024;54:e2250281. https:\/\/doi.org\/10.1002\/eji.202250281.","journal-title":"Eur J Immunol"},{"key":"6627_CR41","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41586-021-04221-8","volume":"601","author":"Z Xu","year":"2022","unstructured":"Xu Z, Chen D, Hu Y, Jiang K, Huang H, Du Y, et al. Anatomically distinct fibroblast subsets determine skin autoimmune patterns. Nature. 2022;601:118\u201324. https:\/\/doi.org\/10.1038\/s41586-021-04221-8.","journal-title":"Nature"},{"key":"6627_CR42","doi-asserted-by":"publisher","unstructured":"Samadi AK, Bilsland A, Georgakilas AG, Amedei A, Amin A, Bishayee A, et al. A multi-targeted approach to suppress tumor-promoting inflammation. Semin Cancer Biol. 2015;35(Suppl):S151\u201384. https:\/\/doi.org\/10.1016\/j.semcancer.2015.03.006.","DOI":"10.1016\/j.semcancer.2015.03.006"},{"key":"6627_CR43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00403-008-0893-7","volume":"301","author":"MM Bashir","year":"2009","unstructured":"Bashir MM, Sharma MR, Werth VP. TNF-alpha production in the skin. Arch Dermatol Res. 2009;301:87\u201391. https:\/\/doi.org\/10.1007\/s00403-008-0893-7.","journal-title":"Arch Dermatol Res"},{"key":"6627_CR44","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1080\/13685538.2020.1806814","volume":"23","author":"E Karagun","year":"2020","unstructured":"Karagun E, Baysak S. Levels of TNF-alpha, IL-6, IL-17, IL-37 cytokines in patients with active vitiligo. Aging Male. 2020;23:1487\u201392. https:\/\/doi.org\/10.1080\/13685538.2020.1806814.","journal-title":"Aging Male"},{"key":"6627_CR45","doi-asserted-by":"publisher","first-page":"155432","DOI":"10.1016\/j.cyto.2021.155432","volume":"140","author":"M Singh","year":"2021","unstructured":"Singh M, Mansuri MS, Kadam A, Palit SP, Dwivedi M, Laddha NC, et al. Tumor necrosis factor-alpha affects melanocyte survival and melanin synthesis via multiple pathways in vitiligo. Cytokine. 2021;140:155432. https:\/\/doi.org\/10.1016\/j.cyto.2021.155432.","journal-title":"Cytokine"},{"key":"6627_CR46","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1159\/000536480","volume":"240","author":"T Dutta","year":"2024","unstructured":"Dutta T, Sengupta S, Adhya S, Saha A, Sengupta D, Mondal R, et al. Identification of TNF-\u03b1 as major susceptible risk locus for vitiligo: a systematic review and meta-analysis study in the Asian population. Dermatology. 2024;240:376\u201386. https:\/\/doi.org\/10.1159\/000536480.","journal-title":"Dermatology"},{"issue":"1","key":"6627_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1046\/j.1432-1327.1998.2550139.x","volume":"255","author":"M Mart\u00ednez-Esparza","year":"1998","unstructured":"Mart\u00ednez-Esparza M, Jim\u00e9nez-Cervantes C, Solano F, Lozano J\u00c1C, Garc\u00eda-Borr\u00f3n JC. Mechanisms of melanogenesis inhibition by tumor necrosis factor-alpha in B16\/F10 mouse melanoma cells. Eur J Biochem. 1998;255(1):139\u201346.","journal-title":"Eur J Biochem"},{"key":"6627_CR48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1755-148X.2011.00945.x","volume":"25","author":"Y Kotobuki","year":"2012","unstructured":"Kotobuki Y, Tanemura A, Yang L, Itoi S, Wataya-Kaneda M, Murota H, et al. Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris. Pigment Cell Melanoma Res. 2012;25:219\u201330. https:\/\/doi.org\/10.1111\/j.1755-148X.2011.00945.x.","journal-title":"Pigment Cell Melanoma Res"},{"key":"6627_CR49","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.molmed.2006.07.008","volume":"12","author":"C Levy","year":"2006","unstructured":"Levy C, Khaled M, Fisher DE. MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med. 2006;12:406\u201314. https:\/\/doi.org\/10.1016\/j.molmed.2006.07.008.","journal-title":"Trends Mol Med"},{"key":"6627_CR50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jdermsci.2008.03.013","volume":"52","author":"K Kingo","year":"2008","unstructured":"Kingo K, Aunin E, Karelson M, R\u00e4tsep R, Silm H, Vasar E, et al. Expressional changes in the intracellular melanogenesis pathways and their possible role in the pathogenesis of vitiligo. J Dermatol Sci. 2008;52:39\u201346. https:\/\/doi.org\/10.1016\/j.jdermsci.2008.03.013.","journal-title":"J Dermatol Sci"},{"key":"6627_CR51","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/path.1538","volume":"202","author":"R Kitamura","year":"2004","unstructured":"Kitamura R, Tsukamoto K, Harada K, Shimizu A, Shimada S, Kobayashi T, et al. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF\/KIT protein interactions and the downstream effector, MITF-M. J Pathol. 2004;202:463\u201375. https:\/\/doi.org\/10.1002\/path.1538.","journal-title":"J Pathol"},{"key":"6627_CR52","doi-asserted-by":"publisher","first-page":"109130","DOI":"10.1016\/j.intimp.2022.109130","volume":"111","author":"M Aliyu","year":"2022","unstructured":"Aliyu M, Zohora FT, Anka AU, Ali K, Maleknia S, Saffarioun M, et al. Interleukin-6 cytokine: an overview of the immune regulation, immune dysregulation, and therapeutic approach. Int Immunopharmacol. 2022;111:109130. https:\/\/doi.org\/10.1016\/j.intimp.2022.109130.","journal-title":"Int Immunopharmacol"},{"key":"6627_CR53","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","volume":"50","author":"S Kang","year":"2019","unstructured":"Kang S, Tanaka T, Narazaki M, Kishimoto T. Targeting interleukin-6 signaling in clinic. Immunity. 2019;50:1007\u201323. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.026.","journal-title":"Immunity"},{"key":"6627_CR54","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/08820139.2020.1813756","volume":"51","author":"M Singh","year":"2022","unstructured":"Singh M, Jadeja SD, Vaishnav J, Mansuri MS, Shah C, Mayatra JM, et al. Investigation of the role of interleukin 6 in vitiligo pathogenesis. Immunol Invest. 2022;51:120\u201337. https:\/\/doi.org\/10.1080\/08820139.2020.1813756.","journal-title":"Immunol Invest"},{"key":"6627_CR55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12348-023-00341-6","volume":"13","author":"LB Ferreira","year":"2023","unstructured":"Ferreira LB, Ashander LM, Appukuttan B, Ma Y, Williams KA, Best G, et al. Human retinal endothelial cells express functional interleukin-6 receptor. J Ophthalmic Inflamm Infect. 2023;13:21. https:\/\/doi.org\/10.1186\/s12348-023-00341-6.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"6627_CR56","doi-asserted-by":"publisher","unstructured":"Rose-John S. Interleukin-6 signalling in health and disease. F1000Res. 2020;9. https:\/\/doi.org\/10.12688\/f1000research.26058.1.","DOI":"10.12688\/f1000research.26058.1"},{"key":"6627_CR57","doi-asserted-by":"publisher","first-page":"713540","DOI":"10.3389\/fimmu.2021.713540","volume":"12","author":"P Ren","year":"2021","unstructured":"Ren P, Lu L, Cai S, Chen J, Lin W, Han F. Alternative splicing: a new cause and potential therapeutic target in autoimmune disease. Front Immunol. 2021;12:713540. https:\/\/doi.org\/10.3389\/fimmu.2021.713540.","journal-title":"Front Immunol"},{"key":"6627_CR58","doi-asserted-by":"publisher","first-page":"1012841","DOI":"10.3389\/fimmu.2023.1012841","volume":"14","author":"A Maali","year":"2023","unstructured":"Maali A, Gholizadeh M, Feghhi-Najafabadi S, Noei A, Seyed-Motahari SS, Mansoori S, et al. Nanobodies in cell-mediated immunotherapy: on the road to fight cancer. Front Immunol. 2023;14:1012841. https:\/\/doi.org\/10.3389\/fimmu.2023.1012841.","journal-title":"Front Immunol"},{"key":"6627_CR59","doi-asserted-by":"publisher","unstructured":"Soler MF, Abaurrea A, Azcoaga P, Araujo AM, Caffarel MM. New perspectives in cancer immunotherapy: targeting IL-6 cytokine family. J Immunother Cancer. 2023;11. https:\/\/doi.org\/10.1136\/jitc-2023-007530.","DOI":"10.1136\/jitc-2023-007530"},{"key":"6627_CR60","doi-asserted-by":"publisher","first-page":"109005","DOI":"10.1016\/j.intimp.2022.109005","volume":"110","author":"YS Li","year":"2022","unstructured":"Li YS, Ren HC, Cao JH. Roles of interleukin-6-mediated immunometabolic reprogramming in COVID-19 and other viral infection-associated diseases. Int Immunopharmacol. 2022;110:109005. https:\/\/doi.org\/10.1016\/j.intimp.2022.109005.","journal-title":"Int Immunopharmacol"},{"issue":"Suppl 1","key":"6627_CR61","first-page":"S4","volume":"65","author":"JY Park","year":"2007","unstructured":"Park JY, Pillinger MH. Interleukin-6 in the pathogenesis of rheumatoid arthritis. Bull NYU Hosp Jt Dis. 2007;65(Suppl 1):S4\u201310.","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"6627_CR62","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2146\/ajhp070449","volume":"65","author":"A Sebba","year":"2008","unstructured":"Sebba A. Tocilizumab: the first interleukin-6-receptor inhibitor. Am J Health Syst Pharm. 2008;65:1413\u20138. https:\/\/doi.org\/10.2146\/ajhp070449.","journal-title":"Am J Health Syst Pharm"},{"key":"6627_CR63","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/s1359-6101(02)00027-8","volume":"13","author":"K Ishihara","year":"2002","unstructured":"Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 2002;13:357\u201368. https:\/\/doi.org\/10.1016\/s1359-6101(02)00027-8.","journal-title":"Cytokine Growth Factor Rev"},{"key":"6627_CR64","doi-asserted-by":"publisher","unstructured":"Tomaszewska K, Kozlowska M, Kaszuba A, Lesiak A, Narbutt J, Zalewska-Janowska A. Increased serum levels of IFN-gamma, IL-1beta, and IL-6 in patients with alopecia areata and nonsegmental vitiligo. Oxid Med Cell Longev. 2020;2020:5693572. https:\/\/doi.org\/10.1155\/2020\/5693572.","DOI":"10.1155\/2020\/5693572"},{"key":"6627_CR65","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0923-1811(02)00151-2","volume":"31","author":"CX Tu","year":"2003","unstructured":"Tu CX, Gu JS, Lin XR. Increased interleukin-6 and granulocyte-macrophage colony stimulating factor levels in the sera of patients with non-segmental vitiligo. J Dermatol Sci. 2003;31:73\u20138. https:\/\/doi.org\/10.1016\/s0923-1811(02)00151-2.","journal-title":"J Dermatol Sci"},{"key":"6627_CR66","first-page":"799","volume":"26","author":"MZ Zailaie","year":"2005","unstructured":"Zailaie MZ. Decreased proinflammatory cytokine production by peripheral blood mononuclear cells from vitiligo patients following aspirin treatment. Saudi Med J. 2005;26:799\u2013805.","journal-title":"Saudi Med J"},{"key":"6627_CR67","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/1523-1747.ep12289743","volume":"108","author":"HS Yu","year":"1997","unstructured":"Yu HS, Chang KL, Yu CL, Li HF, Wu MT, Wu CS, et al. Alterations in IL-6, IL-8, GM-CSF, TNF-alpha, and IFN-gamma release by peripheral mononuclear cells in patients with active vitiligo. J Invest Dermatol. 1997;108:527\u20139. https:\/\/doi.org\/10.1111\/1523-1747.ep12289743.","journal-title":"J Invest Dermatol"},{"key":"6627_CR68","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s00403-012-1277-6","volume":"304","author":"L Yao","year":"2012","unstructured":"Yao L, Hu DN, Chen M, Li SS. Subtoxic levels hydrogen peroxide-induced expression of interleukin-6 by epidermal melanocytes. Arch Dermatol Res. 2012;304:831\u20138. https:\/\/doi.org\/10.1007\/s00403-012-1277-6.","journal-title":"Arch Dermatol Res"},{"key":"6627_CR69","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1038\/jid.2012.181","volume":"132","author":"S Toosi","year":"2012","unstructured":"Toosi S, Orlow SJ, Manga P. Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8. J Invest Dermatol. 2012;132:2601\u20139. https:\/\/doi.org\/10.1038\/jid.2012.181.","journal-title":"J Invest Dermatol"},{"key":"6627_CR70","doi-asserted-by":"publisher","unstructured":"Zwicky P, Unger S, Becher B. Targeting interleukin-17 in chronic inflammatory disease: a clinical perspective. J Exp Med. 2020;217. https:\/\/doi.org\/10.1084\/jem.20191123.","DOI":"10.1084\/jem.20191123"},{"key":"6627_CR71","doi-asserted-by":"publisher","first-page":"e18907","DOI":"10.1371\/journal.pone.0018907","volume":"6","author":"CQ Wang","year":"2011","unstructured":"Wang CQ, Cruz-Inigo AE, Fuentes-Duculan J, Moussai D, Gulati N, Sullivan-Whalen M, et al. Th17 cells and activated dendritic cells are increased in vitiligo lesions. PLoS ONE. 2011;6:e18907. https:\/\/doi.org\/10.1371\/journal.pone.0018907.","journal-title":"PLoS ONE"},{"key":"6627_CR72","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/ijd.14695","volume":"59","author":"N Bernardini","year":"2020","unstructured":"Bernardini N, Skroza N, Tolino E, Mambrin A, Anzalone A, Balduzzi V, et al. IL-17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art. Int J Dermatol. 2020;59:406\u201311. https:\/\/doi.org\/10.1111\/ijd.14695.","journal-title":"Int J Dermatol"},{"key":"6627_CR73","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1684\/ejd.2013.2023","volume":"23","author":"MA Elela","year":"2013","unstructured":"Elela MA, Hegazy RA, Fawzy MM, Rashed LA, Rasheed H. Interleukin 17, Interleukin 22 and FoxP3 expression in tissue and serum of non-segmental vitiligo: a case- controlled study on eighty-four patients. Eur J Dermatol. 2013;23:350\u20135. https:\/\/doi.org\/10.1684\/ejd.2013.2023.","journal-title":"Eur J Dermatol"},{"key":"6627_CR74","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1365-2230.2010.03972.x","volume":"36","author":"DA Bassiouny","year":"2011","unstructured":"Bassiouny DA, Shaker O. Role of interleukin-17 in the pathogenesis of vitiligo. Clin Exp Dermatol. 2011;36:292\u20137. https:\/\/doi.org\/10.1111\/j.1365-2230.2010.03972.x.","journal-title":"Clin Exp Dermatol"},{"key":"6627_CR75","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/jocd.12517","volume":"18","author":"S Sushama","year":"2019","unstructured":"Sushama S, Dixit N, Gautam RK, Arora P, Khurana A, Anubhuti A. Cytokine profile (IL-2, IL-6, IL-17, IL-22, and TNF-alpha) in vitiligo-new insight into pathogenesis of disease. J Cosmet Dermatol. 2019;18:337\u201341. https:\/\/doi.org\/10.1111\/jocd.12517.","journal-title":"J Cosmet Dermatol"},{"key":"6627_CR76","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1038\/jid.2013.237","volume":"133","author":"CQF Wang","year":"2013","unstructured":"Wang CQF, Akalu YT, Suarez-Farinas M, Gonzalez J, Mitsui H, Lowes MA, et al. IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis. J Invest Dermatol. 2013;133:2741\u201352. https:\/\/doi.org\/10.1038\/jid.2013.237.","journal-title":"J Invest Dermatol"},{"key":"6627_CR77","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1084\/jem.191.9.1555","volume":"191","author":"KS Taraszka","year":"2000","unstructured":"Taraszka KS, Higgins JM, Tan K, Mandelbrot DA, Wang JH, Brenner MB. Molecular basis for leukocyte integrin alpha(E)beta(7) adhesion to epithelial (E)-cadherin. J Exp Med. 2000;191:1555\u201367. https:\/\/doi.org\/10.1084\/jem.191.9.1555.","journal-title":"J Exp Med"},{"key":"6627_CR78","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/jcp.10008","volume":"189","author":"P Pla","year":"2001","unstructured":"Pla P, Moore R, Morali OG, Grille S, Martinozzi S, Delmas V, et al. Cadherins in neural crest cell development and transformation. J Cell Physiol. 2001;189:121\u201332. https:\/\/doi.org\/10.1002\/jcp.10008.","journal-title":"J Cell Physiol"},{"key":"6627_CR79","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1046\/j.1365-2133.2003.05024.x","volume":"148","author":"Y Gauthier","year":"2003","unstructured":"Gauthier Y, Cario-Andre M, Lepreux S, Pain C, Ta\u00efeb A. Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo. Br J Dermatol. 2003;148:95\u2013101. https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05024.x.","journal-title":"Br J Dermatol"},{"key":"6627_CR80","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/jid.2015.25","volume":"135","author":"RY Wagner","year":"2015","unstructured":"Wagner RY, Luciani F, Cario-Andr\u00e9 M, Rubod A, Petit V, Benzekri L, et al. Altered E-cadherin levels and distribution in melanocytes precede clinical manifestations of vitiligo. J Invest Dermatol. 2015;135:1810\u20139. https:\/\/doi.org\/10.1038\/jid.2015.25.","journal-title":"J Invest Dermatol"},{"key":"6627_CR81","doi-asserted-by":"publisher","unstructured":"Boukhedouni N, Martins C, Darrigade AS, Drullion C, Rambert J, Barrault C, et al. Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo. JCI Insight. 2020;5. https:\/\/doi.org\/10.1172\/jci.insight.133772.","DOI":"10.1172\/jci.insight.133772"},{"key":"6627_CR82","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/jid.2014.527","volume":"135","author":"M Cavali\u00e9","year":"2015","unstructured":"Cavali\u00e9 M, Ezzedine K, Fontas E, Montaudi\u00e9 H, Castela E, Bahadoran P, et al. Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo-controlled study. J Invest Dermatol. 2015;135:970\u20134. https:\/\/doi.org\/10.1038\/jid.2014.527.","journal-title":"J Invest Dermatol"},{"key":"6627_CR83","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","volume":"46","author":"S Cheuk","year":"2017","unstructured":"Cheuk S, Schlums H, Gallais S\u00e9r\u00e9zal I, Martini E, Chiang SC, Marquardt N, et al. CD49a expression defines tissue-resident CD8(+) T cells poised for cytotoxic function in human skin. Immunity. 2017;46:287\u2013300. https:\/\/doi.org\/10.1016\/j.immuni.2017.01.009.","journal-title":"Immunity"},{"key":"6627_CR84","doi-asserted-by":"publisher","unstructured":"Richmond JM, Strassner JP, Zapata L Jr., Garg M, Riding RL, Refat MA, et al. Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo. Sci Transl Med. 2018;10. https:\/\/doi.org\/10.1126\/scitranslmed.aam7710.","DOI":"10.1126\/scitranslmed.aam7710"},{"key":"6627_CR85","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jid.2017.08.038","volume":"138","author":"K Boniface","year":"2018","unstructured":"Boniface K, Jacquemin C, Darrigade AS, Dessarthe B, Martins C, Boukhedouni N, et al. Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3. J Invest Dermatol. 2018;138:355\u201364. https:\/\/doi.org\/10.1016\/j.jid.2017.08.038.","journal-title":"J Invest Dermatol"},{"key":"6627_CR86","doi-asserted-by":"publisher","unstructured":"Hlaca N, Zagar T, Kastelan M, Brajac I, Prpic-Massari L. Current concepts of vitiligo immunopathogenesis. Biomedicines. 2022;10. https:\/\/doi.org\/10.3390\/biomedicines10071639.","DOI":"10.3390\/biomedicines10071639"},{"key":"6627_CR87","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.4049\/jimmunol.1402256","volume":"194","author":"LK Mackay","year":"2015","unstructured":"Mackay LK, Braun A, Macleod BL, Collins N, Tebartz C, Bedoui S, et al. Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention. J Immunol. 2015;194:2059\u201363. https:\/\/doi.org\/10.4049\/jimmunol.1402256.","journal-title":"J Immunol"},{"key":"6627_CR88","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-94-017-9153-3_7","volume":"819","author":"GA Hadley","year":"2014","unstructured":"Hadley GA, Higgins JM. Integrin \u0391E\u03b27: molecular features and functional significance in the immune system. Adv Exp Med Biol. 2014;819:97\u2013110. https:\/\/doi.org\/10.1007\/978-94-017-9153-3_7.","journal-title":"Adv Exp Med Biol"},{"key":"6627_CR89","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.immuni.2014.12.007","volume":"41","author":"JM Schenkel","year":"2014","unstructured":"Schenkel JM, Masopust D. Tissue-resident memory T cells. Immunity. 2014;41:886\u201397. https:\/\/doi.org\/10.1016\/j.immuni.2014.12.007.","journal-title":"Immunity"},{"key":"6627_CR90","doi-asserted-by":"publisher","unstructured":"Fr\u0105czek A, Owczarczyk-Saczonek A, Placek W. The role of T(RM) cells in the pathogenesis of vitiligo-a review of the current state-of-the-art. Int J Mol Sci. 2020;21. https:\/\/doi.org\/10.3390\/ijms21103552.","DOI":"10.3390\/ijms21103552"},{"key":"6627_CR91","doi-asserted-by":"publisher","first-page":"102868","DOI":"10.1016\/j.autrev.2021.102868","volume":"20","author":"F Shah","year":"2021","unstructured":"Shah F, Patel S, Begum R, Dwivedi M. Emerging role of tissue resident memory T cells in vitiligo: from pathogenesis to therapeutics. Autoimmun Rev. 2021;20:102868. https:\/\/doi.org\/10.1016\/j.autrev.2021.102868.","journal-title":"Autoimmun Rev"},{"key":"6627_CR92","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/ni.2744","volume":"14","author":"LK Mackay","year":"2013","unstructured":"Mackay LK, Rahimpour A, Ma JZ, Collins N, Stock AT, Hafon ML, et al. The developmental pathway for CD103(+)CD8\u2009+\u2009tissue-resident memory T cells of skin. Nat Immunol. 2013;14:1294\u2013301. https:\/\/doi.org\/10.1038\/ni.2744.","journal-title":"Nat Immunol"},{"key":"6627_CR93","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143\u20137. https:\/\/doi.org\/10.1126\/science.284.5411.143.","journal-title":"Science"},{"key":"6627_CR94","doi-asserted-by":"publisher","first-page":"10711","DOI":"10.1073\/pnas.96.19.10711","volume":"96","author":"GC Kopen","year":"1999","unstructured":"Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A. 1999;96:10711\u20136. https:\/\/doi.org\/10.1073\/pnas.96.19.10711.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6627_CR95","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1182\/blood-2005-02-0572","volume":"106","author":"Y Sato","year":"2005","unstructured":"Sato Y, Araki H, Kato J, Nakamura K, Kawano Y, Kobune M, et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood. 2005;106:756\u201363. https:\/\/doi.org\/10.1182\/blood-2005-02-0572.","journal-title":"Blood"},{"key":"6627_CR96","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2174\/1574888x12666170608124303","volume":"12","author":"R Nancarrow-Lei","year":"2017","unstructured":"Nancarrow-Lei R, Mafi P, Mafi R, Khan W. A systemic review of adult mesenchymal stem cell sources and their multilineage differentiation potential relevant to musculoskeletal tissue repair and regeneration. Curr Stem Cell Res Ther. 2017;12:601\u201310. https:\/\/doi.org\/10.2174\/1574888x12666170608124303.","journal-title":"Curr Stem Cell Res Ther"},{"key":"6627_CR97","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8:315\u20137. https:\/\/doi.org\/10.1080\/14653240600855905.","journal-title":"Cytotherapy"},{"key":"6627_CR98","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2014.01.013","volume":"14","author":"M Mendicino","year":"2014","unstructured":"Mendicino M, Bailey Alexander M, Wonnacott K, Puri Raj K, Bauer Steven R. MSC-based product characterization for clinical trials: an FDA perspective. Cell Stem Cell. 2014;14:141\u20135. https:\/\/doi.org\/10.1016\/j.stem.2014.01.013.","journal-title":"Cell Stem Cell"},{"key":"6627_CR99","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","volume":"6","author":"AJ Friedenstein","year":"1968","unstructured":"Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6:230\u201347.","journal-title":"Transplantation"},{"key":"6627_CR100","first-page":"642","volume":"19","author":"C Cao","year":"2005","unstructured":"Cao C, Dong Y, Dong Y. Study on culture and in vitro osteogenesis of blood-derived human mesenchymal stem cells. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2005;19:642\u20137.","journal-title":"Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi"},{"key":"6627_CR101","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1046\/j.1365-2141.2000.01986.x","volume":"109","author":"A Erices","year":"2000","unstructured":"Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000;109:235\u201342. https:\/\/doi.org\/10.1046\/j.1365-2141.2000.01986.x.","journal-title":"Br J Haematol"},{"key":"6627_CR102","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1634\/stemcells.22-5-649","volume":"22","author":"Y Fukuchi","year":"2004","unstructured":"Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, Tsuji K. Human placenta-derived cells have mesenchymal stem\/progenitor cell potential. Stem Cells. 2004;22:649\u201358. https:\/\/doi.org\/10.1634\/stemcells.22-5-649.","journal-title":"Stem Cells"},{"key":"6627_CR103","doi-asserted-by":"publisher","unstructured":"In \u2018t Anker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH, Willemze R, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood. 2003;102:1548\u20131549. https:\/\/doi.org\/10.1182\/blood-2003-04-1291.","DOI":"10.1182\/blood-2003-04-1291"},{"key":"6627_CR104","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1161\/circresaha.109.205260","volume":"106","author":"H Tsuji","year":"2010","unstructured":"Tsuji H, Miyoshi S, Ikegami Y, Hida N, Asada H, Togashi I, et al. Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ Res. 2010;106:1613\u201323. https:\/\/doi.org\/10.1161\/circresaha.109.205260.","journal-title":"Circ Res"},{"key":"6627_CR105","doi-asserted-by":"publisher","first-page":"13625","DOI":"10.1073\/pnas.240309797","volume":"97","author":"S Gronthos","year":"2000","unstructured":"Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A. 2000;97:13625\u201330. https:\/\/doi.org\/10.1073\/pnas.240309797.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6627_CR106","first-page":"104","volume":"5","author":"B Heidari","year":"2013","unstructured":"Heidari B, Shirazi A, Akhondi MM, Hassanpour H, Behzadi B, Naderi MM, et al. Comparison of proliferative and multilineage differentiation potential of sheep mesenchymal stem cells derived from bone marrow, liver, and adipose tissue. Avicenna J Med Biotechnol. 2013;5:104\u201317.","journal-title":"Avicenna J Med Biotechnol"},{"key":"6627_CR107","doi-asserted-by":"publisher","first-page":"e43255","DOI":"10.1371\/journal.pone.0043255","volume":"7","author":"N Fekete","year":"2012","unstructured":"Fekete N, Rojewski MT, F\u00fcrst D, Kreja L, Ignatius A, Dausend J, et al. GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC. PLoS ONE. 2012;7:e43255. https:\/\/doi.org\/10.1371\/journal.pone.0043255.","journal-title":"PLoS ONE"},{"key":"6627_CR108","doi-asserted-by":"publisher","unstructured":"Lechanteur C, Briquet A, Bettonville V, Baudoux E, Beguin Y. MSC manufacturing for academic clinical trials: from a clinical-grade to a full GMP-compliant process. Cells. 2021;10. https:\/\/doi.org\/10.3390\/cells10061320.","DOI":"10.3390\/cells10061320"},{"key":"6627_CR109","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-3-030-11096-3_10","volume":"1123","author":"W Wang","year":"2019","unstructured":"Wang W, Han ZC. Heterogeneity of human mesenchymal stromal\/stem cells. Adv Exp Med Biol. 2019;1123:165\u201377. https:\/\/doi.org\/10.1007\/978-3-030-11096-3_10.","journal-title":"Adv Exp Med Biol"},{"key":"6627_CR110","first-page":"154","volume":"2","author":"AG Via","year":"2012","unstructured":"Via AG, Frizziero A, Oliva F. Biological properties of mesenchymal stem cells from different sources. Muscles Ligaments Tendons J. 2012;2:154\u201362.","journal-title":"Muscles Ligaments Tendons J"},{"key":"6627_CR111","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/scrt442","volume":"5","author":"PR Amable","year":"2014","unstructured":"Amable PR, Teixeira MV, Carias RB, Granjeiro JM, Borojevic R. Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton\u2019s jelly. Stem Cell Res Ther. 2014;5:53. https:\/\/doi.org\/10.1186\/scrt442.","journal-title":"Stem Cell Res Ther"},{"key":"6627_CR112","doi-asserted-by":"publisher","first-page":"e17616","DOI":"10.7717\/peerj.17616","volume":"12","author":"N Yi","year":"2024","unstructured":"Yi N, Zeng Q, Zheng C, Li S, Lv B, Wang C, et al. Functional variation among mesenchymal stem cells derived from different tissue sources. PeerJ. 2024;12:e17616. https:\/\/doi.org\/10.7717\/peerj.17616.","journal-title":"PeerJ"},{"key":"6627_CR113","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jcyt.2017.03.001","volume":"19","author":"AB Ara\u00fajo","year":"2017","unstructured":"Ara\u00fajo AB, Salton GD, Furlan JM, Schneider N, Angeli MH, Laureano \u00c1M, et al. Comparison of human mesenchymal stromal cells from four neonatal tissues: amniotic membrane, chorionic membrane, placental decidua and umbilical cord. Cytotherapy. 2017;19:577\u201385. https:\/\/doi.org\/10.1016\/j.jcyt.2017.03.001.","journal-title":"Cytotherapy"},{"key":"6627_CR114","doi-asserted-by":"publisher","unstructured":"Kim JH, Jo CH, Kim HR, Hwang YI. Comparison of immunological characteristics of mesenchymal stem cells from the periodontal ligament, umbilical cord, and adipose tissue. Stem Cells Int. 2018;2018:8429042. https:\/\/doi.org\/10.1155\/2018\/8429042.","DOI":"10.1155\/2018\/8429042"},{"key":"6627_CR115","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-bioeng-070909-105309","volume":"12","author":"B Parekkadan","year":"2010","unstructured":"Parekkadan B, Milwid JM. Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng. 2010;12:87\u2013117. https:\/\/doi.org\/10.1146\/annurev-bioeng-070909-105309.","journal-title":"Annu Rev Biomed Eng"},{"key":"6627_CR116","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/sj.leu.2404550","volume":"21","author":"L Fouillard","year":"2007","unstructured":"Fouillard L, Chapel A, Bories D, Bouchet S, Costa JM, Rouard H, et al. Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation. Leukemia. 2007;21:568\u201370. https:\/\/doi.org\/10.1038\/sj.leu.2404550.","journal-title":"Leukemia"},{"key":"6627_CR117","doi-asserted-by":"publisher","unstructured":"Zeng L, Yu G, Yang K, Xiang W, Li J, Chen H. Efficacy and safety of mesenchymal stem cell transplantation in the treatment of autoimmune diseases (Rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, and ankylosing Spondylitis): A Systematic Review and Meta-Analysis of Randomized Controlled Trial. Stem Cells Int. 2022;2022:9463314. https:\/\/doi.org\/10.1155\/2022\/9463314.","DOI":"10.1155\/2022\/9463314"},{"key":"6627_CR118","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2174\/1574888x13666180913123424","volume":"14","author":"A Golchin","year":"2019","unstructured":"Golchin A, Farahany TZ, Khojasteh A, Soleimanifar F, Ardeshirylajimi A. The clinical trials of mesenchymal stem cell therapy in skin diseases: an update and concise review. Curr Stem Cell Res Ther. 2019;14:22\u201333. https:\/\/doi.org\/10.2174\/1574888x13666180913123424.","journal-title":"Curr Stem Cell Res Ther"},{"key":"6627_CR119","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3727\/096368910x520065","volume":"20","author":"C Nie","year":"2011","unstructured":"Nie C, Yang D, Xu J, Si Z, Jin X, Zhang J. Locally administered adipose-derived stem cells accelerate wound healing through differentiation and vasculogenesis. Cell Transpl. 2011;20:205\u201316. https:\/\/doi.org\/10.3727\/096368910x520065.","journal-title":"Cell Transpl"},{"key":"6627_CR120","doi-asserted-by":"publisher","first-page":"e92676","DOI":"10.1371\/journal.pone.0092676","volume":"9","author":"R Hu","year":"2014","unstructured":"Hu R, Ling W, Xu W, Han D. Fibroblast-like cells differentiated from adipose-derived mesenchymal stem cells for vocal fold wound healing. PLoS ONE. 2014;9:e92676. https:\/\/doi.org\/10.1371\/journal.pone.0092676.","journal-title":"PLoS ONE"},{"key":"6627_CR121","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-4939-3584-0_7","volume":"1416","author":"M Gnecchi","year":"2016","unstructured":"Gnecchi M, Danieli P, Malpasso G, Ciuffreda MC. Paracrine mechanisms of mesenchymal stem cells in tissue repair. Methods Mol Biol. 2016;1416:123\u201346. https:\/\/doi.org\/10.1007\/978-1-4939-3584-0_7.","journal-title":"Methods Mol Biol"},{"key":"6627_CR122","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4161\/org.27405","volume":"10","author":"A Nuschke","year":"2014","unstructured":"Nuschke A. Activity of mesenchymal stem cells in therapies for chronic skin wound healing. Organogenesis. 2014;10:29\u201337. https:\/\/doi.org\/10.4161\/org.27405.","journal-title":"Organogenesis"},{"key":"6627_CR123","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/stem.503","volume":"28","author":"QZ Zhang","year":"2010","unstructured":"Zhang QZ, Su WR, Shi SH, Wilder-Smith P, Xiang AP, Wong A, et al. Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells. 2010;28:1856\u201368. https:\/\/doi.org\/10.1002\/stem.503.","journal-title":"Stem Cells"},{"key":"6627_CR124","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4252\/wjsc.v6.i5.526","volume":"6","author":"JD Glenn","year":"2014","unstructured":"Glenn JD, Whartenby KA. Mesenchymal stem cells: emerging mechanisms of immunomodulation and therapy. World J Stem Cells. 2014;6:526\u201339. https:\/\/doi.org\/10.4252\/wjsc.v6.i5.526.","journal-title":"World J Stem Cells"},{"key":"6627_CR125","doi-asserted-by":"publisher","first-page":"e0177533","DOI":"10.1371\/journal.pone.0177533","volume":"12","author":"T de Mayo","year":"2017","unstructured":"de Mayo T, Conget P, Becerra-Bayona S, Sossa CL, Galvis V, Arango-Rodr\u00edguez ML. The role of bone marrow mesenchymal stromal cell derivatives in skin wound healing in diabetic mice. PLoS ONE. 2017;12:e0177533. https:\/\/doi.org\/10.1371\/journal.pone.0177533.","journal-title":"PLoS ONE"},{"key":"6627_CR126","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/5584_2018_256","volume":"1119","author":"A Golchin","year":"2018","unstructured":"Golchin A, Rekabgardan M, Taheri RA, Nourani MR. Promotion of cell-based therapy: special focus on the cooperation of mesenchymal stem cell therapy and gene therapy for clinical trial studies. Adv Exp Med Biol. 2018;1119:103\u201318. https:\/\/doi.org\/10.1007\/5584_2018_256.","journal-title":"Adv Exp Med Biol"},{"key":"6627_CR127","doi-asserted-by":"publisher","first-page":"e55640","DOI":"10.1371\/journal.pone.0055640","volume":"8","author":"SJ Hong","year":"2013","unstructured":"Hong SJ, Jia SX, Xie P, Xu W, Leung KP, Mustoe TA, et al. Topically delivered adipose derived stem cells show an activated-fibroblast phenotype and enhance granulation tissue formation in skin wounds. PLoS ONE. 2013;8:e55640. https:\/\/doi.org\/10.1371\/journal.pone.0055640.","journal-title":"PLoS ONE"},{"key":"6627_CR128","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1089\/ten.tea.2015.0277","volume":"22","author":"R Kosaraju","year":"2016","unstructured":"Kosaraju R, Rennert RC, Maan ZN, Duscher D, Barrera J, Whittam AJ, et al. Adipose-derived stem cell-seeded hydrogels increase endogenous progenitor cell recruitment and neovascularization in wounds. Tissue Eng Part A. 2016;22:295\u2013305. https:\/\/doi.org\/10.1089\/ten.tea.2015.0277.","journal-title":"Tissue Eng Part A"},{"key":"6627_CR129","doi-asserted-by":"publisher","unstructured":"Shephard MT, Merkhan MM, Forsyth NR. Human mesenchymal stem cell secretome driven T cell immunomodulation is IL-10 dependent. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms232113596.","DOI":"10.3390\/ijms232113596"},{"key":"6627_CR130","doi-asserted-by":"publisher","first-page":"999","DOI":"10.4252\/wjsc.v15.i11.999","volume":"15","author":"H Li","year":"2023","unstructured":"Li H, Ji XQ, Zhang SM, Bi RH. Hypoxia and inflammatory factor preconditioning enhances the immunosuppressive properties of human umbilical cord mesenchymal stem cells. World J Stem Cells. 2023;15:999\u20131016. https:\/\/doi.org\/10.4252\/wjsc.v15.i11.999.","journal-title":"World J Stem Cells"},{"key":"6627_CR131","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12929-021-00725-7","volume":"28","author":"WZ Zhuang","year":"2021","unstructured":"Zhuang WZ, Lin YH, Su LJ, Wu MS, Jeng HY, Chang HC, et al. Mesenchymal stem\/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications. J Biomed Sci. 2021;28:28. https:\/\/doi.org\/10.1186\/s12929-021-00725-7.","journal-title":"J Biomed Sci"},{"key":"6627_CR132","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-022-00932-0","volume":"7","author":"Y Han","year":"2022","unstructured":"Han Y, Yang J, Fang J, Zhou Y, Candi E, Wang J, et al. The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Signal Transduct Target Ther. 2022;7:92. https:\/\/doi.org\/10.1038\/s41392-022-00932-0.","journal-title":"Signal Transduct Target Ther"},{"key":"6627_CR133","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/art.27548","volume":"62","author":"L Sun","year":"2010","unstructured":"Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H, et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 2010;62:2467\u201375. https:\/\/doi.org\/10.1002\/art.27548.","journal-title":"Arthritis Rheum"},{"key":"6627_CR134","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10067-012-1943-2","volume":"31","author":"D Shi","year":"2012","unstructured":"Shi D, Wang D, Li X, Zhang H, Che N, Lu Z, et al. Allogeneic transplantation of umbilical cord-derived mesenchymal stem cells for diffuse alveolar hemorrhage in systemic lupus erythematosus. Clin Rheumatol. 2012;31:841\u20136. https:\/\/doi.org\/10.1007\/s10067-012-1943-2.","journal-title":"Clin Rheumatol"},{"key":"6627_CR135","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/bmt.2012.184","volume":"48","author":"X Li","year":"2013","unstructured":"Li X, Wang D, Liang J, Zhang H, Sun L. Mesenchymal SCT ameliorates refractory cytopenia in patients with systemic lupus erythematosus. Bone Marrow Transpl. 2013;48:544\u201350. https:\/\/doi.org\/10.1038\/bmt.2012.184.","journal-title":"Bone Marrow Transpl"},{"key":"6627_CR136","doi-asserted-by":"publisher","unstructured":"G\u00f3mez-Ferrer M, Amaro-Prellezo E, Dorronsoro A, S\u00e1nchez-S\u00e1nchez R, Vicente \u00c1, Cos\u00edn-Roger J, et al. HIF-overexpression and pro-inflammatory priming in human mesenchymal stromal cells improves the healing properties of extracellular vesicles in experimental Crohn\u2019s disease. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms222011269.","DOI":"10.3390\/ijms222011269"},{"key":"6627_CR137","doi-asserted-by":"publisher","unstructured":"Ting-ting X. PB-MSCs induce macrophage M2 polarization throughIL-10\/STAT3 signaling pathway for the treatment of acne:an in vivo experimental study. 2023. https:\/\/doi.org\/10.27680\/d.cnki.gzyyc.2023.000304.","DOI":"10.27680\/d.cnki.gzyyc.2023.000304"},{"key":"6627_CR138","doi-asserted-by":"publisher","first-page":"101592","DOI":"10.1016\/j.trim.2022.101592","volume":"72","author":"QM Pang","year":"2022","unstructured":"Pang QM, Qian NN, Zou WH, Yang YC, Chen H, Zhang M, et al. PBMSCs transplantation facilitates functional recovery after spinal cord injury by regulating microglia\/macrophages plasticity. Transpl Immunol. 2022;72:101592. https:\/\/doi.org\/10.1016\/j.trim.2022.101592.","journal-title":"Transpl Immunol"},{"key":"6627_CR139","doi-asserted-by":"publisher","unstructured":"Meng Z. Regulation of oxidative stress by peripheral bloodmesenchymal stem cells on melanocytes of vitiligo mice in vitro. 2023. https:\/\/doi.org\/10.27680\/d.cnki.gzyyc.2023.000582.","DOI":"10.27680\/d.cnki.gzyyc.2023.000582"},{"key":"6627_CR140","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1365-2222.2010.03685.x","volume":"41","author":"JM Brown","year":"2011","unstructured":"Brown JM, Nemeth K, Kushnir-Sukhov NM, Metcalfe DD, Mezey E. Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanism. Clin Exp Allergy. 2011;41:526\u201334. https:\/\/doi.org\/10.1111\/j.1365-2222.2010.03685.x.","journal-title":"Clin Exp Allergy"},{"key":"6627_CR141","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","volume":"2","author":"G Ren","year":"2008","unstructured":"Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008;2:141\u201350. https:\/\/doi.org\/10.1016\/j.stem.2007.11.014.","journal-title":"Cell Stem Cell"},{"key":"6627_CR142","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrrheum.2009.104","volume":"5","author":"F Djouad","year":"2009","unstructured":"Djouad F, Bouffi C, Ghannam S, No\u00ebl D, Jorgensen C. Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. Nat Rev Rheumatol. 2009;5:392\u20139. https:\/\/doi.org\/10.1038\/nrrheum.2009.104.","journal-title":"Nat Rev Rheumatol"},{"key":"6627_CR143","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","volume":"107","author":"A Corcione","year":"2006","unstructured":"Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, et al. Human mesenchymal stem cells modulate B-cell functions. Blood. 2006;107:367\u201372. https:\/\/doi.org\/10.1182\/blood-2005-07-2657.","journal-title":"Blood"},{"key":"6627_CR144","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1634\/stemcells.2004-0359","volume":"24","author":"PA Sotiropoulou","year":"2006","unstructured":"Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells. 2006;24:74\u201385. https:\/\/doi.org\/10.1634\/stemcells.2004-0359.","journal-title":"Stem Cells"},{"key":"6627_CR145","doi-asserted-by":"publisher","unstructured":"Huang Y, Wu Q, Tam PKH. Immunomodulatory mechanisms of mesenchymal stem cells and their potential clinical applications. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms231710023.","DOI":"10.3390\/ijms231710023"},{"key":"6627_CR146","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","volume":"14","author":"Y Shi","year":"2018","unstructured":"Shi Y, Wang Y, Li Q, Liu K, Hou J, Shao C, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018;14:493\u2013507. https:\/\/doi.org\/10.1038\/s41581-018-0023-5.","journal-title":"Nat Rev Nephrol"},{"key":"6627_CR147","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s00018-017-2473-5","volume":"74","author":"N Li","year":"2017","unstructured":"Li N, Hua J. Interactions between mesenchymal stem cells and the immune system. Cell Mol Life Sci. 2017;74:2345\u201360. https:\/\/doi.org\/10.1007\/s00018-017-2473-5.","journal-title":"Cell Mol Life Sci"},{"key":"6627_CR148","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1089\/scd.2009.0365","volume":"19","author":"H Hemeda","year":"2010","unstructured":"Hemeda H, Jakob M, Ludwig AK, Giebel B, Lang S, Brandau S. Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells. Stem Cells Dev. 2010;19:693\u2013706. https:\/\/doi.org\/10.1089\/scd.2009.0365.","journal-title":"Stem Cells Dev"},{"key":"6627_CR149","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.trim.2009.08.002","volume":"22","author":"X Lu","year":"2009","unstructured":"Lu X, Liu T, Gu L, Huang C, Zhu H, Meng W, et al. Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets. Transpl Immunol. 2009;22:55\u201361. https:\/\/doi.org\/10.1016\/j.trim.2009.08.002.","journal-title":"Transpl Immunol"},{"key":"6627_CR150","doi-asserted-by":"publisher","first-page":"e60254","DOI":"10.1371\/journal.pone.0060254","volume":"8","author":"MN Zhou","year":"2013","unstructured":"Zhou MN, Zhang ZQ, Wu JL, Lin FQ, Fu LF, Wang SQ, et al. Dermal mesenchymal stem cells (DMSCs) inhibit skin-homing CD8\u2009+\u2009T cell activity, a determining factor of vitiligo patients\u2019 autologous melanocytes transplantation efficiency. PLoS ONE. 2013;8:e60254. https:\/\/doi.org\/10.1371\/journal.pone.0060254.","journal-title":"PLoS ONE"},{"key":"6627_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.08.027","author":"IH Hamzavi","year":"2024","unstructured":"Hamzavi IH, Ganesan AK, Mahmoud BH, Weiss E, Ahmed AM, Robinson D, et al. Effective and durable repigmentation for stable vitiligo: a randomized within-subject controlled trial assessing treatment with autologous skin cell suspension transplantation. J Am Acad Dermatol. 2024. https:\/\/doi.org\/10.1016\/j.jaad.2024.08.027.","journal-title":"J Am Acad Dermatol"},{"key":"6627_CR152","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2340\/00015555-1174","volume":"92","author":"JY Kim","year":"2012","unstructured":"Kim JY, Park CD, Lee JH, Lee CH, Do BR, Lee AY. Co-culture of melanocytes with adipose-derived stem cells as a potential substitute for co-culture with keratinocytes. Acta Derm Venereol. 2012;92:16\u201323. https:\/\/doi.org\/10.2340\/00015555-1174.","journal-title":"Acta Derm Venereol"},{"key":"6627_CR153","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1387\/ijdb.041793ld","volume":"48","author":"LD Derycke","year":"2004","unstructured":"Derycke LD, Bracke ME. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int J Dev Biol. 2004;48:463\u201376. https:\/\/doi.org\/10.1387\/ijdb.041793ld.","journal-title":"Int J Dev Biol"},{"issue":"Pt 4","key":"6627_CR154","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1242\/jcs.107.4.983","volume":"107","author":"A Tang","year":"1994","unstructured":"Tang A, Eller MS, Hara M, Yaar M, Hirohashi S, Gilchrest BA. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci. 1994;107(Pt 4):983\u201392. https:\/\/doi.org\/10.1242\/jcs.107.4.983.","journal-title":"J Cell Sci"},{"key":"6627_CR155","doi-asserted-by":"publisher","first-page":"328","DOI":"10.4062\/biomolther.2014.065","volume":"22","author":"WS Lim","year":"2014","unstructured":"Lim WS, Kim C-H, Kim J-Y, Do BR, Kim E-J, Lee A-Y. Adipose-derived stem cells improve efficacy of melanocyte transplantation in animal skin. Biomolecules Ther. 2014;22:328\u201333.","journal-title":"Biomolecules Ther"},{"key":"6627_CR156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2376-0427.1000256","volume":"4","author":"AA Saleh","year":"2017","unstructured":"Saleh AA, Abdel-salam OH, Metwally HG, Abdelsalam HA, Hassan AM, Sosa WS. Comparison treatment of vitiligo by co-culture of melanocytes derived from hair follicle with adipose-derived stem cells with and without NB-UVB. J Pigmentary Disorders. 2017;4:1\u20138.","journal-title":"J Pigmentary Disorders"},{"key":"6627_CR157","doi-asserted-by":"crossref","unstructured":"Fahmy DH, Elfar NN, Shaker ESE, Ahmed AY, Mostafa WA, Ibrahim ZA. Adipose derived stem cells in the treatment of vitiligo. Journal of Advances in Medicine and Medical Research; 2022.","DOI":"10.9734\/jammr\/2022\/v34i234890"},{"key":"6627_CR158","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.jcyt.2015.03.328","volume":"17","author":"H Gabr","year":"2015","unstructured":"Gabr H, Elkheir WA. Combined local melanocytes and systemic mesenchymal stem cell injection in vitiligo treatment. Cytotherapy. 2015;17:S13. https:\/\/doi.org\/10.1016\/j.jcyt.2015.03.328.","journal-title":"Cytotherapy"},{"key":"6627_CR159","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1007\/s00403-023-02692-5","volume":"315","author":"J Liu","year":"2023","unstructured":"Liu J, Liu S, Guo M, Yong M, Hu Z. Clinical validation and study of stem cell transplantation in treatment of vitiligo. Arch Dermatol Res. 2023;315:2983\u20134. https:\/\/doi.org\/10.1007\/s00403-023-02692-5.","journal-title":"Arch Dermatol Res"},{"key":"6627_CR160","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jaad.2006.08.017","volume":"56","author":"J Kwinter","year":"2007","unstructured":"Kwinter J, Pelletier J, Khambalia A, Pope E. High-potency steroid use in children with vitiligo: a retrospective study. J Am Acad Dermatol. 2007;56:236\u201341. https:\/\/doi.org\/10.1016\/j.jaad.2006.08.017.","journal-title":"J Am Acad Dermatol"},{"key":"6627_CR161","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1001\/archderm.139.5.581","volume":"139","author":"V Lepe","year":"2003","unstructured":"Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% Clobetasol for the treatment of childhood vitiligo. Arch Dermatol. 2003;139:581\u20135. https:\/\/doi.org\/10.1001\/archderm.139.5.581.","journal-title":"Arch Dermatol"},{"key":"6627_CR162","doi-asserted-by":"publisher","unstructured":"Felsten LM, Alikhan A, Petronic-Rosic V. Vitiligo: a comprehensive overview: part II: treatment options and approach to treatment. J Am Acad Dermatol. 2011;65:493\u2013514. https:\/\/doi.org\/10.1016\/j.jaad.2010.10.043.","DOI":"10.1016\/j.jaad.2010.10.043"},{"key":"6627_CR163","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1067\/mjd.2001.113475","volume":"44","author":"S Radakovic-Fijan","year":"2001","unstructured":"Radakovic-Fijan S, F\u00fcrnsinn-Friedl AM, H\u00f6nigsmann H, Tanew A. Oral dexamethasone pulse treatment for vitiligo. J Am Acad Dermatol. 2001;44:814\u20137. https:\/\/doi.org\/10.1067\/mjd.2001.113475.","journal-title":"J Am Acad Dermatol"},{"key":"6627_CR164","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40257-022-00752-6","volume":"24","author":"KN Cunningham","year":"2023","unstructured":"Cunningham KN, Rosmarin D. Vitiligo treatments: review of current therapeutic modalities and JAK inhibitors. Am J Clin Dermatol. 2023;24:165\u201386. https:\/\/doi.org\/10.1007\/s40257-022-00752-6.","journal-title":"Am J Clin Dermatol"},{"key":"6627_CR165","doi-asserted-by":"publisher","unstructured":"Bishnoi A, Parsad D. Clinical and molecular aspects of vitiligo treatments. Int J Mol Sci. 2018;19. https:\/\/doi.org\/10.3390\/ijms19051509.","DOI":"10.3390\/ijms19051509"},{"key":"6627_CR166","doi-asserted-by":"publisher","first-page":"986918","DOI":"10.3389\/fimmu.2022.986918","volume":"13","author":"Y Feng","year":"2022","unstructured":"Feng Y, Lu Y. Advances in vitiligo: update on therapeutic targets. Front Immunol. 2022;13:986918. https:\/\/doi.org\/10.3389\/fimmu.2022.986918.","journal-title":"Front Immunol"},{"key":"6627_CR167","doi-asserted-by":"publisher","unstructured":"Diotallevi F, Gioacchini H, De Simoni E, Marani A, Candelora M, Paolinelli M, et al. Vitiligo, from pathogenesis to therapeutic advances: state of the art. Int J Mol Sci. 2023;24. https:\/\/doi.org\/10.3390\/ijms24054910.","DOI":"10.3390\/ijms24054910"},{"key":"6627_CR168","unstructured":"Haq M, Adnan G, Ruxolitinib. StatPearls. StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC. Treasure Island (FL). 2024."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06627-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06627-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06627-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:05:01Z","timestamp":1751360701000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06627-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":168,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6627"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06627-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"707"}}